World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201412000967245
Date of registration: 10/12/2014
Prospective Registration: Yes
Primary sponsor: dike franklin
Public title: Pharmacological enhancement of motor function recovery in patients with ischaemic stroke: a trial of fluoxetine.
Scientific title: Pharmacological enhancement of motor function recovery in patients with ischaemic stroke: a trial of fluoxetine.
Date of first enrolment: 01/01/2015
Target sample size: 60
Recruitment status: Pending
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=967
Study type:  Interventional
Study design:  Parallel: different groups receive different interventions at same time during study,Randomised,Permuted block randomization, using blocks of 6, non-varied.,Sealed opaque envelopes  
Phase:  Phase-0
Countries of recruitment
Nigeria
Contacts
Name: Bertha    Ekeh
Address:  Abak road Uyo 530001 Uyo Nigeria
Telephone: +2348034018391
Email: berthacekeh@yahoo.com
Affiliation:  consultant neurologist
Name: Dike    franklin
Address:  Abak road Uyo 530001 uyo Nigeria
Telephone: +2347033038651
Email: frankincense4m@yahoo.com
Affiliation:  senior registrar
Key inclusion & exclusion criteria
Inclusion criteria: (1) 18- 85yrs of age
(2) Ischaemic stroke, unilateral, supra-tentorialconfirmed by neuroimaging.
(3) Presentation within first 14 days of ictus
(4) NIHSS score (5) Hemiparesis or hemiplegia, FMMS (6) Informed consent.

Exclusion criteria: (1) Glasgow coma score < 8,
(2) NIHSS score >16
(3) Cardiovascular/metabolic /respiratory instability-: hypertensive emergency or hypotension/ acidosis or alkalosis/ RR >24cycles per min.
(4) Previous central /peripheral nerve injury
(5) Concurrent medications interacting with SSRI¿s
(6) Haemorrhagic stroke on CT
(7) Substantial premorbid disability
(8) Depression (Montgomery-Åsberg Depression Rating Scale MADRS score >19), taking anti-depressant drugs, MAOI, neuroleptic drugs or benzodiazepines during the month before inclusion.
(9) Pregnancy.
(10) No consent.


Age minimum: 18 Year(s)
Age maximum: 85 Year(s)
Gender: Both
Health Condition(s) or Problem(s) studied
Stroke

Stroke
Intervention(s)
standard treatment
fluoxetine plus standard treatment
Primary Outcome(s)
Changes in Fugl Meyr Motor score
Secondary Outcome(s)
NIHSS, mRS
Secondary ID(s)
Source(s) of Monetary Support
franklin Dike
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 29/10/2014
Contact:
Uyo Institute of Health Research Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history